UDK: 616.24-002.2:316.34]:303.62(497.7)
Kovachevikj K.1, Janevska S.1,Kovachevikj M.2,KondovaTopuzovska I.3
1PHI,Family medicine practice “Vita Katerina”, Skopje, Republic of N. Macedonia
2Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia
3 University Clinic for Infectious Diseases and Febrile Conditions, Faculty of Medicine, University of “Saints Cyril and Methodius”, Skopje, Republic of N. Macedonia
| Janevska Sashka | https://orcid.org/0000-0003-1247-3297 |
| Kondova Topuzovska Irena | https://orcid.org/0000-0001-5641-0779 |
Abstract
Introduction. Chronic obstructive pulmonary disease (COPD)is one of the most common respiratory diseases. However, it remains significantly unrecognized and undiagnosed in clinical practice.The aim of this study is to investigate the association between sociodemographic and clinical characteristics of patients with newly diagnosed chronic obstructive pulmonary disease in a population aged ≥ 40.
Materials and Methods.A one-year cross-sectional study was conducted in a family medicine practice in Skopje, including individuals aged 40 to 75 years without respiratory complaints. Sociodemographic questionnaires and six screening tests for COPD were evaluated. COPD diagnosis is established by spirometry, defined as a postbronchodilator FEV1/FVC ratio <0,70.
Results. The total number of participants was 175, of which 18 participants (9%) had newly diagnosed COPD.These participants were significantly older (p=0.003), male (p=0.03), with a low level of education (p=0.008), mainly workers (p=0.045), heavy smokers ≥30 pack/years (p=0.0007), or were exposed to biomass fuels (p=0.036). Tuberculosis (p=0.028),arterial hypertension (p=0.045), family history of respiratory disease (p=0.0135), chronic respiratory disease in childhood (p=0.001) and one lower respiratory tract infection in the last year (p=0.0447) were identified as significant risk factors for COPD.
Conclusion.A considerable proportion (9%) of asymptomatic adults aged ≥40 years had previously undiagnosed COPD. Older age, male sex, lower level of education, heavy smoking, biomass exposure, tuberculosis, hypertension, family history of respiratory disease, and recurrent childhood infections were significantly associated with newly diagnosed COPD.
Keywords:Chronic obstructive pulmonary disease; primary health care; questionnaires;risk factors; sociodemographic characteristics.
References:
1. Global Initiative for Chronic Obstructive Lung Disease; Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2025 Report). Published online 2025. Accessed February 10, 2026. https://goldcopd.org/2025-gold-report/
2. Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022 ;10(5):447-458. doi:10.1016/S2213-2600(21)00511-7
3. Ferrari AJ, Santomauro DF, Aali A, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403(10440):2133-2161. doi:10.1016/S0140-6736(24)00757-8
4. МинистерствоназдравствонаРепубликаСеверна Македонија, Упатствозапрактикувањенамедициназасновананадоказизатретманнапациентсохроничнаобструктивнабелодробнаболест-ХОББ нанивона примарназдравственазаштита . Accessed February 10, 2026. https://portal.mdt.gov.mk/post-body-files/upatstva-za-praktikuvanje-na-medicina-zasnovana-na-dokazi-file-fVVX.pdf
5. Минов Ј (ур.). Хроничнаопструктивнабелодробнаболест. Скопје: Медицинскифакултет Универзитет ,,СвКирил и Методиј”, 2023.
6. Agustí A, Melén E, DeMeo DL, et al. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene–environment interactions across the lifespan. Lancet Respir Med. Elsevier Ltd. 2022;10(5):512-524. doi:10.1016/S2213-2600(21)00555-5
7. Soriano JB, Abajobir AA, Abate KH, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691-706. doi:10.1016/S2213-2600(17)30293-X
8. Marti T. Primary Health Care Organization, Performance and Quality in North Macedonia. 2019. Accessed February 10, 2026. https://www.who.int/europe/publications/i/item/WHO-EURO-2019-3609-43368-60838
9. Minov J, Stoleski S, Stikova E, et al. COPD in a sample of the general adult population from the Skopje region. Academic Medical Journal. 2022;2(1):47-58.doi:10.53582/amj2221047m
10. Stanley AJ, Hasan I, Crockett AJ, et al. COPD Diagnostic Questionnaire (CDQ) for selecting at-risk patients for spirometry: A cross-sectional study in Australian general practice. NPJ Prim Care Respir Med. 2014;24. doi:10.1038/npjpcrm.2014.24
11. Martinez FJ, Mannino D, Leidy NK, et al. A new approach for identifying patients with undiagnosed chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(6):748-756. doi:10.1164/rccm.201603-0622OC
12. Zhou YM, Chen SY, Tian J, et al. Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China. International Journal of Tuberculosis and Lung Disease. 2013;17(12). doi:10.5588/ijtld.12.0995
13. Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. 2006;73(3):285-295. doi:10.1159/000090142
14. Zhang Q, Wang M, Li X, et al. Do symptom-based questions help screen COPD among Chinese populations? Sci Rep. 2016;6. doi:10.1038/srep30419
15. Buist S, Mcburnie MA, Vollmer WM, et al. International Variation in the Prevalence of COPD (The BOLD Study): A Population-Based Prevalence Study. Vol 370. 2007. www.thelancet.com
16. Quach A, Giovannelli J, Chérot-Kornobis N, et al. Prevalence and underdiagnosis of airway obstruction among middle-aged adults in northern France: The ELISABET study 2011-2013. Respir Med. 2015;109(12):1553-1561. doi: 10.1016/j.rmed.2015.10.012
17. Menezes AMB, Perez-Padilla R, Jardim JRB, et al. PLATINO Study: Chronic obstructive pulmonary disease in five Latin American cities. Lancet. 2005; 366:1875-1881. doi: 10.1016/S0140-6736(05)67632-5
18. Lytras T, Kogevinas M, Kromhout H, et al. Occupational exposures and 20-year incidence of COPD: the European Community Respiratory Health Survey. Thorax. 2018;73(11). doi:10.1136/thoraxjnl-2017-211158ï
19. Stoleski S, Minov J, Mijakoski D, et al. COPD prevalence and characteristics among sample of working population. Front Public Health. 2025;13. doi:10.3389/fpubh.2025.1598290
20. Beran D, Zar HJ, Perrin C, et al. Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries. Lancet Respir Med. Lancet Publishing Group. 2015. 3(2):159-170. doi:10.1016/S2213-2600(15)00004-1
21. Gershon AS, Warner L, Cascagnette P, et al. Lifetime risk of developing chronic obstructive pulmonary disease: A longitudinal population study. The Lancet. 2011. 378(9795):991-996. doi:10.1016/S0140-6736(11)60990-2
22. Colak Y, LøkkeA, Marott JL, et al. Low smoking exposure and development and prognosis of COPD over four decades: a population-based cohort study. EurRespir J. Published. 2024. 64(3). doi:10.1183/13993003.00314-2024
23. Hu G, Zhou Y, Tian J, et al. Risk of COPD From Exposure to biomass smoke: a meta-analysis. CHEST journal. 2010;138 (1):20-31. doi: 10.1378/chest.08-2114
24. Rennard SI, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet. 2006.367: 1216-1219. doi:10.1016/S0140-6736(06)68516-4
25. Forouzanfar MH, Alexander L, Anderson HR, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015;386(10010):2287-2323. doi:10.1016/S0140-6736(15)00128-2
26. Eisner MD, Balmes J, Katz PP, et al. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health. 2005;4. doi:10.1186/1476-069X-4-7
27. McCloskey SC, Bipen PD, Hinchliffe SJ, et al. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med. 2001; 164:1419-1424. doi:10.1164/rccm2105002
28. Stick S. Paediatric origins of adult lung disease c 1 The contribution of airway development to paediatric and adult lung disease. Thorax. 2000
29. Lange P, Celli B, Agustí A, et al. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. New England Journal of Medicine. 2015;373(2):111-122. doi:10.1056/nejmoa1411532
30. Svanes C. What has the ECRHS told us about the childhood risks of asthma, allergy and lung function? Clin Respir J. 2008;2 Suppl 1:34-44. doi:10.1111/j.1752-699X.2008. 00082.x
31. Liang X, Chou OHI, Cheung BMY. The association between systemic arterial hypertension and chronic obstructive pulmonary disease: results from the U.S. National Health and Nutrition Examination Survey 1999–2018: a cross-sectional study. Chronic ObstrPulm Dis (Miami). 2023;10(2):190-198.
32. Martins SM, Dickens AP, Salibe-Filho W, et al. Accuracy and economic evaluation of screening tests for undiagnosed COPD among hypertensive individuals in Brazil. NPJ Prim Care Respir Med. 2022;32(1). doi:10.1038/s41533-022-00303-w
33. Feng J, Hu M, Duan H. Bidirectional association between tuberculosis and chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Clin Med. 2025;14(21):7639. doi:10.3390/jcm14217639.
34. Јанковска A, Симоновска В, Крстев Б. Анализанасостојбатасотуберкулозаза 2023 годиназаСкопскиотрегионспореденосопериодотод 2010-2022 година. ЈЗУ Центарзајавноздравје – Скопје; 2024.